These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21323567)

  • 1. Interferon: current status and future prospects in cancer therapy.
    Wang BX; Rahbar R; Fish EN
    J Interferon Cytokine Res; 2011 Jul; 31(7):545-52. PubMed ID: 21323567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future prospects and subject of the liver cancer stem cells study for the clinical application.
    Haraguchi N; Ishii H; Nagano H; Doki Y; Mori M
    Gastroenterology; 2011 Feb; ():. PubMed ID: 21354165
    [No Abstract]   [Full Text] [Related]  

  • 3. Antitumour actions of interferons: implications for cancer therapy.
    Parker BS; Rautela J; Hertzog PJ
    Nat Rev Cancer; 2016 Mar; 16(3):131-44. PubMed ID: 26911188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of RCN1 promotes pyroptosis in acute myeloid leukemia cells.
    Deng S; Pan Y; An N; Chen F; Chen H; Wang H; Xu X; Liu R; Yang L; Wang X; Du X; Zhang Q
    Mol Oncol; 2023 Dec; 17(12):2584-2602. PubMed ID: 37746742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergent Role of IFITM1/3 towards Splicing Factor (SRSF1) and Antigen-Presenting Molecule (HLA-B) in Cervical Cancer.
    Gómez-Herranz M; Faktor J; Yébenes Mayordomo M; Pilch M; Nekulova M; Hernychova L; Ball KL; Vojtesek B; Hupp TR; Kote S
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36008984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel insight into pancreatic adenocarcinoma pathogenesis using liquid association analysis.
    Shokati Eshkiki Z; Khayer N; Talebi A; Karbalaei R; Akbari A
    BMC Med Genomics; 2022 Feb; 15(1):30. PubMed ID: 35180880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus.
    Goad DW; Bressy C; Holbrook MC; Grdzelishvili VZ
    Mol Ther Oncolytics; 2022 Mar; 24():59-76. PubMed ID: 34977342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactive nanotherapeutic trends to combat triple negative breast cancer.
    Chowdhury P; Ghosh U; Samanta K; Jaggi M; Chauhan SC; Yallapu MM
    Bioact Mater; 2021 Oct; 6(10):3269-3287. PubMed ID: 33778204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19.
    Schreiber G
    Front Immunol; 2020; 11():595739. PubMed ID: 33117408
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Bayne RS; Puckett S; Rodrigues LU; Cramer SD; Lee J; Furdui CM; Chou JW; Miller LD; Ornelles DA; Lyles DS
    Mol Ther Oncolytics; 2020 Jun; 17():496-507. PubMed ID: 32529027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells.
    Seegers SL; Frasier C; Greene S; Nesmelova IV; Grdzelishvili VZ
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell Cycle Arrest in G
    Bressy C; Droby GN; Maldonado BD; Steuerwald N; Grdzelishvili VZ
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. USP6 Confers Sensitivity to IFN-Mediated Apoptosis through Modulation of TRAIL Signaling in Ewing Sarcoma.
    Henrich IC; Young R; Quick L; Oliveira AM; Chou MM
    Mol Cancer Res; 2018 Dec; 16(12):1834-1843. PubMed ID: 30131449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update.
    Felt SA; Grdzelishvili VZ
    J Gen Virol; 2017 Dec; 98(12):2895-2911. PubMed ID: 29143726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies.
    Li G; Bonamici N; Dey M; Lesniak MS; Balyasnikova IV
    Expert Opin Drug Deliv; 2018 Feb; 15(2):163-172. PubMed ID: 28895435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ruxolitinib and Polycation Combination Treatment Overcomes Multiple Mechanisms of Resistance of Pancreatic Cancer Cells to Oncolytic Vesicular Stomatitis Virus.
    Felt SA; Droby GN; Grdzelishvili VZ
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I Interferons Impede Short Hairpin RNA-Mediated RNAi via Inhibition of Dicer-Mediated Processing to Small Interfering RNA.
    Machitani M; Sakurai F; Wakabayashi K; Takayama K; Tachibana M; Mizuguchi H
    Mol Ther Nucleic Acids; 2017 Mar; 6():173-182. PubMed ID: 28325284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Essential Role of Type I Interferons in Differentiation and Activation of Tumor-Associated Neutrophils.
    Pylaeva E; Lang S; Jablonska J
    Front Immunol; 2016; 7():629. PubMed ID: 28066438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage-based cell therapies: The long and winding road.
    Lee S; Kivimäe S; Dolor A; Szoka FC
    J Control Release; 2016 Oct; 240():527-540. PubMed ID: 27422609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-α potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer.
    Buoncervello M; Romagnoli G; Buccarelli M; Fragale A; Toschi E; Parlato S; Lucchetti D; Macchia D; Spada M; Canini I; Sanchez M; Falchi M; Musella M; Biffoni M; Belardelli F; Capone I; Sgambato A; Vitiani LR; Gabriele L
    Oncotarget; 2016 May; 7(18):26361-73. PubMed ID: 27028869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.